Glycostem
Glycostem is a clinical-stage company, harvesting the power of allogeneic cells like Natural Killer (NK) cells or antigen presenting cell in the field of cellular cancer immunotherapy.
Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.
Glycostem is a clinical-stage company, harvesting the power of allogeneic cells like Natural Killer (NK) cells or antigen presenting cell in the field of cellular cancer immunotherapy.